Back to Market Feed

ETHOSUXIMIDE 250 MG/5 ML SOLN

ETHOSUXIMIDE
$0.0942per ML
Low Outlier

Strength

250 mg/5mL

Manufacturer

PAI Holdings LLC

NDC

00121067016

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ETHOSUXIMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA040253

On Market Since

11/22/2000

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+2.2%

3M

+2.5%

6M

+5.4%

1Y

-2.4%

3Y

+0.1%

5Y

-51.3%

All

-59.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0211
per EA